Testosterone replacement therapy (TRT) at standard doses causes a small but real increase in blood pressure. In the largest safety trial to date, men on testosterone saw their systolic blood pressure rise by about 0.3 mmHg over six months, while the placebo group’s dropped by 1.5 mmHg. That gap is statistically significant but modest. The real concern starts when doses climb well above therapeutic levels, where the blood pressure effects become far more pronounced.
What the Largest Trial Found
The TRAVERSE trial, published in the New England Journal of Medicine, enrolled thousands of men with low testosterone and at least one cardiovascular risk factor. After six months, the testosterone group’s average systolic blood pressure barely moved (up 0.3 mmHg), while the placebo group’s actually dropped by 1.5 mmHg. In practical terms, that means TRT prevented the small decline you’d expect from being enrolled in a clinical trial with regular monitoring and follow-up, but it didn’t cause the kind of spike that would alarm most physicians on its own.
This doesn’t mean testosterone is harmless for blood pressure. It means that at prescribed doses, in a monitored setting, the effect on blood pressure readings is small. The mechanisms testosterone sets in motion, however, can create larger problems for certain people, especially over time.
How Testosterone Pushes Blood Pressure Up
Testosterone affects blood pressure through several overlapping pathways, not just one. Understanding these helps explain why some men notice changes and others don’t.
Increased Red Blood Cell Production
One of testosterone’s most predictable effects is stimulating your bone marrow to produce more red blood cells, a condition called erythrocytosis when it goes too far. Testosterone does this in two ways: it increases iron availability by suppressing a hormone that locks iron away, and it converts partly into estradiol, which directly boosts blood cell production and survival. More red blood cells make your blood thicker and more viscous, which forces your heart to work harder to push it through your vessels. Symptoms of this thickened blood include headaches, fatigue, blurred vision, and tingling in the hands or feet. Data from the Framingham Heart Study showed a clear link between higher red blood cell concentration and cardiovascular disease over a 34-year follow-up.
Effects on Blood Vessel Signaling
Your blood vessels have two types of receptors that work in opposition. One type (AT1R) constricts vessels and raises pressure, while the other (AT2R) relaxes them and lowers it. Testosterone shifts the balance toward constriction. In animal studies, removing testosterone from the equation dropped the ratio of constricting-to-relaxing receptors by 75%, essentially making the blood vessels much less reactive to signals that raise blood pressure. Restoring testosterone brought that ratio right back up. This means testosterone plays a “permissive role,” as researchers describe it. It doesn’t raise blood pressure on its own in every situation, but it sets the stage for other signals in the body to push pressure higher than they otherwise would.
Reduced Nitric Oxide
Your blood vessels rely on nitric oxide to stay relaxed and flexible. At high testosterone levels, the gene responsible for producing nitric oxide in vessel walls gets dialed down, and the body’s antioxidant defenses also weaken. The result is stiffer, less responsive blood vessels. This effect appears most clearly at supraphysiological doses, the kind used in bodybuilding rather than medical therapy.
Prescribed Doses vs. High-Dose Use
The Endocrine Society recommends 75 to 100 mg per week for men with clinically low testosterone. At these levels, the blood pressure changes seen in trials are minimal. Anabolic steroid users, by contrast, commonly take 5 to 29 times the therapeutic dose. The difference in cardiovascular impact is dramatic.
In mouse studies comparing normal physiology to supraphysiological testosterone, only the high-dose group developed elevated blood pressure. Their mean arterial pressure jumped from about 100 mmHg to 127 mmHg, a clinically significant increase driven by vascular inflammation, reduced nitric oxide, and blood vessel dysfunction. High-dose testosterone also triggered an inflammatory pathway in blood vessel walls that doesn’t activate at normal levels. This is why the cardiovascular risks of anabolic steroid abuse are in a different category from those of monitored TRT.
Who Faces Higher Risk
Not everyone on TRT responds the same way. Your baseline health matters more than testosterone itself in determining whether your blood pressure climbs. Men who already have thicker blood, sleep apnea, or untreated high blood pressure are more vulnerable to the red blood cell and vascular effects described above.
Interestingly, some of the men who benefit most metabolically from testosterone are those you might expect to be at highest risk. Older, obese men with chronic low-grade inflammation showed the strongest improvements in waist circumference, blood sugar, cholesterol, and triglycerides when their testosterone was brought to mid-normal levels. In multivariate analysis, age, BMI, and baseline inflammation were independent predictors of getting the greatest metabolic benefit from therapy. This creates a nuanced picture: testosterone can improve several cardiovascular risk factors while simultaneously introducing new ones like thicker blood and shifted vascular signaling.
What Gets Monitored and Why
The Endocrine Society’s guidelines call for checking your red blood cell concentration (hematocrit) at baseline, again at 3 to 6 months after starting therapy, and then annually. If your hematocrit rises above 54%, therapy should be paused until it drops back to a safe range. You’ll also be evaluated for sleep apnea and low oxygen levels, both of which can independently drive red blood cell production higher and compound the problem.
Blood pressure itself isn’t singled out in the monitoring guidelines as a standalone check, largely because the direct effect at therapeutic doses is small. But because testosterone influences blood pressure through indirect pathways, especially hematocrit, keeping those numbers in range is functionally a blood pressure strategy. If your hematocrit creeps up, your blood gets thicker, and your pressure follows. Catching it early, usually through a simple blood draw, prevents the cascade.
When blood pressure does rise during TRT, the typical response involves reducing the testosterone dose, increasing the interval between injections, or switching formulations. Addressing the hematocrit issue specifically, sometimes through therapeutic blood donation, can also bring pressure back down without stopping therapy entirely.
The Bottom Line on TRT and Blood Pressure
At prescribed doses with proper monitoring, testosterone’s direct effect on blood pressure is small, roughly 1 to 2 mmHg higher than you’d see without it. The indirect effects, particularly thickened blood from increased red blood cell production and shifted signaling in blood vessel walls, are the real mechanisms to watch. These are manageable with routine blood work but can become serious if ignored. At the supraphysiological doses common in steroid abuse, the picture changes entirely: blood pressure rises substantially, blood vessels stiffen, and inflammatory damage accumulates in ways that prescribed TRT simply doesn’t produce.